AstraZeneca immunotherapy combo flunks another lung cancer study

AstraZeneca immunotherapy combo flunks another lung cancer study - MedCity News

- August 22, 2019

AstraZeneca immunotherapy combo flunks another lung cancer study MedCity News

The company said Wednesday that the pairing of PD-L1 inhibitor Imfinzi and CTLA-4 inhibitor tremelimumab did not prolong overall survival in previously ...

Search This Blog

Lung Cancer

AstraZeneca immunotherapy combo flunks another lung cancer study - MedCity News

Comments

Post a Comment

Popular posts from this blog

Beagles, other dogs could be used to help in early detection of lung cancers, study finds - Fox 32 Chicago

Not An Ordinary Cough: Lung Cancer Symptoms That You Might Neglect - International Business Times

Beagles, other dogs could be used to help in early detection of lung cancers, study finds - Fox 32 Chicago